Novel intranasal pertussis vaccine based on bacterium-like particles as a mucosal adjuvant.

导出 LinkOut

翻译打印收藏纠错

作者： Wei,Shi ^[1] ; Yiming,Kou ^[1] ; Hao,Jiang ^[2] ; Feng,Gao ^[3] ; Wei,Kong ^[3] ; Weiheng,Su ^[3] ; Fei,Xu ^[4] ; Chunlai,Jiang ^[5]

作者单位： National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, P.R. China. ^[1] The Third Hospital of Jilin University, Jilin University, Changchun 130012, P.R. China. ^[2] National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, P.R. China; Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, P.R. China. ^[3] National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, P.R. China; Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, P.R. China. Electronic address: feixu@jlu.edu.cn. ^[4] National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, P.R. China; Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, P.R. China. Electronic address: jiangcl@jlu.edu.cn. ^[5]

关键词 Adjuvant Bacterium-like particles Intranasal Mucosal immunity Pertussis vaccine